NCT03891329已完成不适用
BIO|MASTER.Cor Family Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 130
- 试验地点
- 13
- 主要终点
- Cor Family-related Serious Adverse Device Effect (SADE)-Free Rate Until 3-month Follow-up
研究概览
简要总结
Post-Market Clinical Follow-up of the new Cor Family ICDs/CRT-Ds (Acticor, Rivacor) and the new Plexa ProMRI S DX right ventricular lead to provide post-market data and supporting evidence for the clinical safety and performance of the devices.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 99 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Standard indication for ICD or CRT-D therapy according to clinical guidelines
- •Planned for de novo implantation of an ICD/CRT-D, or upgrade/exchange from existing ICD/CRT-D or pacemaker implant
- •Able to understand the nature of study and to provide written informed consent
- •Willing and able to perform all follow-up visits at the study site
- •Willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept
排除标准
- •Contraindication to ICD and CRT-D therapy
- •Planned for implantation of a CRT-DX system
- •For VR-T DX devices: permanent atrial tachyarrhythmia
- •For VR-T DX devices: patients requiring atrial pacing
- •Less than 18 years old
- •Pregnant or breast feeding
- •Participating in another interventional clinical investigation
- •Life-expectancy is less than 12 months
- •Cardiac surgical procedure planned within 12 months after implantation (including interventional procedures like ablation, valve replacement, heart transplant etc.). Procedures to occur during or prior to implantation are not exclusionary
结局指标
主要结局
Cor Family-related Serious Adverse Device Effect (SADE)-Free Rate Until 3-month Follow-up
时间窗: 3 months
Serious Adverse Device Effect (SADE)-free rate possibly or securely related to the Cor Family Internal Cardioverter Defibrillators (ICDs) / Cardiac Resynchronisation Therapy-Defibrillators (CRT-Ds) until 3-month follow-up
次要结局
- Kaplan-Meier Estimate for the Cor Family Related SADE-free Rate(3 months, 12 months)
- Number of Handling-Assessments of the Automatic LV VectorOpt Test (CRT-devices Only) by the Investigator(3 months)
- Number of Handling-Assessments for the Overall Handling of the CRT AutoAdapt Feature (CRT-devices Only) by the Investigator(3 months)
研究者
研究点 (13)
Loading locations...
相似试验
已完成
不适用
BIO|MASTER.Ilivia Family / PlexaTachyarrhythmiaHeart FailureNCT02774616Biotronik SE & Co. KG292
已完成
不适用
Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)Coronary Artery DiseaseNCT03809715B. Braun Melsungen AG3,520
已完成
不适用
Evaluation of Clareon Vivity/Vivity ToricAphakiaNCT05852470Alcon Research155
已完成
不适用
PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous GraftArteriovenous Graft ThrombosisNCT05071872Straub Medical AG127
招募中
不适用
Post Market Clinical Follow-up of CODMAN CERTAS Programmable ValveHydrocephalus in ChildrenNPH (Normal Pressure Hydrocephalus)IIH - Idiopathic Intracranial HypertensionPost-Traumatic HydrocephalusHemorrhagic StrokeHydrocephalusBrain TumorNCT05397106Integra LifeSciences Corporation158